News

Zacks Small Cap Research on MSN1mon
MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00.
On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission ... remarkable for a completely hands-free, unconstrained autonomous system.
Miami Herald1mon
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation ...
Yahoo Finance29d
MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.
On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that the company can move forward with ...
Benzinga.com1mon
EXCLUSIVE: FDA Approves Monogram Technologies' mBôs TKA System For Knee Surgery
Monogram received FDA 510(k) clearance for its robotic-assisted total ... finds profits in volatile markets. Claim your 7-day free trial now. Monogram Tech may Market the Monogram mBôs TKA ...